The algorithm can be viewed here.
Recent Stories for Testing
Mayo Clinic’s launch of eight new next-generation sequencing (NGS) panels is intended to improve the lives of patients and families living with inherited cardiac conditions by aiding in the diagnosis and management of these complex disorders. These disorders include hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, Noonan syndrome, Marfan syndrome, long QT syndrome, and Brugada syndrome.
Other Posts for Testing
- Connective Tissue Diseases Cascade Test-Ordering [Algorithm]
- Alpha1 Antitrypsin – Comprehensive Testing [Algorithm]
- RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor [A Test in Focus]
- Fabry Disease: Newborn Screen-Positive Follow-up [Algorithm]
- Fabry Disease Testing [Algorithm]
- Acylcarnitine – Newborn Screening | Newborn Screening Follow-up for Elevations of C8, C6, and C10 Acylcarnitines [Algorithm]
- Postmortem Screening [Algorithm]
- Acylcarnitine – Newborn Screening | Newborn Screening Follow-up for Isolated C5 Acylcarnitine Elevations [Algorithm]
- Acylcarnitine – Newborn Screening | Newborn Screening Follow-up for Isolated C4 Acylcarnitine Elevations [Algorithm]
- Maternal Screening | Sequential Maternal Serum Screening Testing Process [Algorithm]